In this study, we demonstrated for the first time a potential role of HTATIP2/TIP30 in ovarian cancer which will enlighten future studies targeting HTATIP2/TIP30 in ovarian cancer treatment, diagnosis, and prevention. This evidence concerns the gene HTATIP2 and ovarian carcinoma.